The abrdn Healthcare Opportunities Fund (THQ) is highlighted as the best all-round healthcare closed-end fund for 2026 due to its broad sector exposure, attractive 11.53% monthly distribution, and a discount to net asset value that has recently widened to -5.97%, below its one-year average. The fund balances large-cap healthcare stocks with higher-risk biotech positions, aiming to capitalize on the healthcare sector's recovery while accepting elevated leverage and expenses. This makes THQ a high-beta investment suited for those seeking growth in healthcare rather than a defensive income source. Investors should consider the fund's risk profile alongside its income potential as the sector continues to recover.
Morgan Stanley lowered Avis Budget Group's price target from $99 to $95 as the company faces a class-action lawsuit accusing major investor Pentwater Capital Management of manipulating its stock price. The lawsuit claims Pentwater artificially inflat...
Deutsche Bank has reiterated a Buy rating for The Estée Lauder Companies, signaling confidence in the stock despite industry challenges like cautious consumer spending and supply-chain risks. Estée Lauder's focus on innovation, brand building, and di...
The Chief Operating Officer of Gen Digital sold 28,248 shares recently. This insider sale could indicate a personal financial decision or a strategic move, which investors might watch closely for signals about the company's outlook. While such sales ...
Needham analyst Mike Cikos raised the price target for ServiceNow to $155, citing the company's AI products surpassing $1 billion in annual contract value (ACV) and a ninefold increase in customers using its agentic AI products. ServiceNow aims to ex...
Analyst firm Cowen & Co. maintained a Hold rating on Paychex (NASDAQ:PAYX) while raising its price target from $98 to $117, reflecting confidence in the company's strong financial performance. Paychex has seen a 30% stock increase over six months, dr...
